Filed: 11/14/2024ACC: 0000905148-24-003147
📋 What this filing means
VENBIO PARTNERS LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $194.33M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$194.33M
Total AUM (reported)
22.80M
Total Shares
Allocation by class
COM$194.33M100.0%
Portfolio Concentration
Top 3$134.20M69.1%
4–10$60.13M30.9%
Top 3 weight
69.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 22.80M
Sole
Full voting authority
22.80M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
PHARVARIS N V
SOLEShares4.29M
TypeSH
Market value$79.44M
40.88%
Sole
4.29M
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares2.83M
TypeSH
Market value$30.18M
15.53%
Sole
2.83M
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares614.59K
TypeSH
Market value$24.58M
12.65%
Sole
614.59K
Shared
0.00
None
0.00
ARTIVA BIOTHERAPEUTICS INC
SOLEShares1.52M
TypeSH
Market value$23.48M
12.08%
Sole
1.52M
Shared
0.00
None
0.00
ACELYRIN INC
SOLEShares3.85M
TypeSH
Market value$18.99M
9.77%
Sole
3.85M
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares9.70M
TypeSH
Market value$17.65M
9.08%
Sole
9.70M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PHARVARIS N VSOLE | COM | 4.29M | SH | $79.44M 40.88% | 4.29M | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 2.83M | SH | $30.18M 15.53% | 2.83M | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 614.59K | SH | $24.58M 12.65% | 614.59K | 0.00 | 0.00 |
ARTIVA BIOTHERAPEUTICS INCSOLE | COM | 1.52M | SH | $23.48M 12.08% | 1.52M | 0.00 | 0.00 |
ACELYRIN INCSOLE | COM | 3.85M | SH | $18.99M 9.77% | 3.85M | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 9.70M | SH | $17.65M 9.08% | 9.70M | 0.00 | 0.00 |